▁Introduction 7.8203125
: 1.90625
<0x0A> 6.52734375
In 3.412109375
▁an 4.54296875
▁era 2.763671875
▁of 0.828125
▁techn 4.5546875
ological 0.056365966796875
▁adv 1.0302734375
anc 1.0625
ements 0.0008997917175292969
▁and 1.412109375
▁scientific 3.83984375
▁break 1.7060546875
through 0.005275726318359375
s 0.01708984375
, 0.0687255859375
▁ph 7.19921875
arma 0.5439453125
ce 0.1298828125
ut 6.937980651855469e-05
ical 0.0029850006103515625
▁companies 0.92626953125
▁play 5.109375
▁a 0.1510009765625
▁critical 2.0703125
▁role 0.00482177734375
▁in 0.003803253173828125
▁pushing 6.80859375
▁the 0.0802001953125
▁boundaries 0.09808349609375
▁of 0.009735107421875
▁medical 1.6435546875
▁innov 1.689453125
ation 0.053314208984375
. 0.63916015625
▁Among 5.82421875
st 2.064453125
▁them 2.88671875
, 0.130615234375
▁Sky 9.875
e 2.150390625
Ph 1.6640625
arma 0.01114654541015625
, 2.001953125
▁a 0.2459716796875
▁ren 3.69921875
owned 0.0006875991821289062
▁name 2.84765625
▁in 0.143798828125
▁the 0.059844970703125
▁ph 1.14453125
arma 0.001735687255859375
ce 0.1168212890625
ut 1.6570091247558594e-05
ical 0.0029296875
▁industry 0.1168212890625
, 0.06817626953125
▁is 1.7685546875
▁predict 13.9765625
ing 0.0714111328125
▁an 3.060546875
▁exception 3.470703125
ally 2.197265625
▁prom 2.1640625
ising 0.00017595291137695312
▁year 1.853515625
▁for 1.7568359375
▁invest 5.06640625
ors 0.041412353515625
▁in 1.7412109375
▁ 0.12744140625
1 8.40625
9 0.70361328125
9 0.20751953125
8 1.5830078125
. 0.1505126953125
▁With 2.154296875
▁a 1.1396484375
▁sle 4.359375
w 0.007312774658203125
▁of 0.0010013580322265625
▁exc 2.220703125
iting 4.410743713378906e-05
▁projects 2.58203125
▁and 1.6640625
▁cutting 4.45703125
- 0.0017948150634765625
edge 0.00023734569549560547
▁research 1.8779296875
, 1.4072265625
▁the 0.72216796875
▁company 0.07427978515625
▁is 0.2113037109375
▁set 2.126953125
▁to 0.01090240478515625
▁revolution 1.796875
ize 0.031829833984375
▁the 0.050567626953125
▁health 2.44140625
care 0.01047515869140625
▁landscape 1.001953125
, 2.734375
▁capt 6.265625
uring 0.45703125
▁the 0.303466796875
▁attention 0.367431640625
▁of 0.035614013671875
▁invest 0.732421875
ors 0.00939178466796875
▁seeking 5.03515625
▁bold 5.8671875
▁and 1.1064453125
▁prof 3.51171875
itable 0.01409149169921875
▁vent 1.0068359375
ures 0.0005621910095214844
. 0.060577392578125
<0x0A> 0.333984375
Em 8.390625
b 0.4501953125
ark 1.140625
ing 0.26806640625
▁on 0.02001953125
▁a 0.45166015625
▁J 1.2353515625
our 0.0007719993591308594
ney 3.790855407714844e-05
▁of 0.384521484375
▁In 1.568359375
nov 0.0182342529296875
ation 0.0218048095703125
: 0.36669921875
<0x0A> 0.303466796875
S 0.53271484375
ky 0.00128936767578125
e 0.0005865097045898438
Ph 0.005954742431640625
arma 0.0011835098266601562
, 1.4599609375
▁known 3.904296875
▁for 0.0265350341796875
▁its 0.09283447265625
▁excell 4.8125
ence 0.0005650520324707031
▁in 0.11798095703125
▁drug 1.7412109375
▁delivery 0.58837890625
▁systems 1.66796875
, 0.1854248046875
▁has 1.3876953125
▁been 1.142578125
▁at 1.2744140625
▁the 0.0005908012390136719
▁fore 0.01454925537109375
front 4.863739013671875e-05
▁of 0.0012731552124023438
▁developing 2.701171875
▁novel 1.5927734375
▁and 2.00390625
▁advanced 3.078125
▁ph 2.439453125
arma 0.00504302978515625
ce 0.01027679443359375
ut 2.1696090698242188e-05
ical 0.0005388259887695312
▁techn 2.19921875
ologies 0.00012886524200439453
. 0.2130126953125
▁By 4.78125
▁providing 4.98828125
▁efficient 3.625
▁solutions 2.88671875
▁to 0.841796875
▁enh 3.4609375
ance 0.00021898746490478516
▁the 0.52197265625
▁effect 2.2265625
iveness 0.0036067962646484375
▁of 0.8681640625
▁medic 1.2734375
ations 0.5693359375
, 0.25927734375
▁the 0.1875
▁company 0.0111846923828125
▁has 0.73095703125
▁gar 3.728515625
ner 6.4373016357421875e-06
ed 1.728534698486328e-05
▁significant 2.17578125
▁recognition 1.7099609375
. 4.08984375
▁It 5.5703125
▁bo 3.681640625
asts 0.00324249267578125
▁a 0.529296875
▁diverse 1.8603515625
▁pipeline 5.5625
▁of 0.1754150390625
▁projects 1.673828125
, 0.464111328125
▁including 1.10546875
▁its 4.39453125
▁revolution 4.16796875
ary 0.0010099411010742188
▁drug 2.720703125
▁delivery 0.2457275390625
▁nan 9.3359375
ote 0.411376953125
chn 0.0257110595703125
ology 0.05419921875
▁and 2.6171875
▁the 3.283203125
▁development 0.96435546875
▁of 0.002140045166015625
▁alternative 6.5078125
▁administration 7.078125
▁routes 0.7939453125
▁for 1.017578125
▁established 3.455078125
▁medic 1.7109375
ations 0.360107421875
. 0.131103515625
<0x0A> 0.546875
F 3.9765625
ore 2.58984375
front 6.67578125
▁of 0.114013671875
▁D 1.615234375
rug 0.0206756591796875
▁D 0.114501953125
elivery 0.00016832351684570312
▁Nan 1.9765625
ote 0.0007867813110351562
chn 0.001850128173828125
ology 0.00327301025390625
: 0.1051025390625
<0x0A> 0.0220947265625
S 0.71142578125
ky 0.0037326812744140625
e 0.00045800209045410156
Ph 0.003711700439453125
arma 0.0004627704620361328
' 1.576171875
s 0.0002732276916503906
▁innov 2.259765625
ative 0.08807373046875
▁approach 1.8779296875
▁to 0.0977783203125
▁drug 0.146240234375
▁delivery 0.01763916015625
▁emphas 9.09375
izes 0.0030689239501953125
▁revolution 8.1875
izing 0.81494140625
▁patients 6.5546875
' 0.02655029296875
▁lives 0.796875
▁by 1.017578125
▁impro 1.95703125
ving 0.0004436969757080078
▁the 0.67138671875
▁effect 1.6083984375
iveness 0.0025959014892578125
▁and 0.8095703125
▁convenience 1.9150390625
▁of 0.002658843994140625
▁medic 0.58056640625
ation 1.60546875
▁administration 0.99267578125
. 0.01806640625
▁In 3.828125
▁ 1.6572265625
1 0.1024169921875
9 0.001468658447265625
9 0.00484466552734375
8 0.08697509765625
, 0.00550079345703125
▁the 0.09503173828125
▁company 0.01111602783203125
▁a 3.8125
ims 0.0017461776733398438
▁to 0.005931854248046875
▁introduce 3.65234375
▁a 1.3193359375
▁range 2.671875
▁of 0.00010311603546142578
▁nan 2.236328125
ote 0.2152099609375
chn 0.03082275390625
ology 0.06396484375
- 0.209228515625
based 0.06658935546875
▁drug 1.4228515625
▁delivery 0.03704833984375
▁systems 0.55029296875
, 0.58837890625
▁ens 5.95703125
uring 1.2993812561035156e-05
▁the 2.63671875
▁target 4.6640625
ed 0.1583251953125
▁release 1.8525390625
▁of 0.04034423828125
▁th 2.541015625
era 8.106231689453125e-06
pe 1.1920928955078125e-06
ut 1.1920928955078125e-06
ics 1.4228515625
. 2.23046875
▁This 1.8037109375
▁novel 3.3203125
▁approach 0.78125
▁shows 8.78125
▁prom 2.4296875
ising 0.0005984306335449219
▁potential 1.0576171875
▁in 1.19140625
▁tre 1.75390625
ating 1.3470649719238281e-05
▁various 1.599609375
▁dise 0.86083984375
ases 2.8371810913085938e-05
, 0.314208984375
▁including 0.346923828125
▁can 4.22265625
cers 0.0002713203430175781
, 0.394287109375
▁chron 2.70703125
ic 5.9723854064941406e-05
▁a 4.3359375
il 0.0009412765502929688
ments 5.817413330078125e-05
, 0.0084991455078125
▁and 0.0438232421875
▁inf 1.544921875
ect 0.0006003379821777344
ious 0.00017559528350830078
▁dise 0.218994140625
ases 8.702278137207031e-06
. 0.1484375
▁In 4.6640625
vest 0.4619140625
ors 0.06805419921875
▁can 0.85400390625
▁anticip 2.01953125
ate 1.0371208190917969e-05
▁significant 1.0859375
▁adv 3.6015625
anc 0.1158447265625
ements 7.62939453125e-06
▁and 2.603515625
▁lic 10.125
ens 0.01995849609375
ing 0.0002608299255371094
▁opportun 1.2353515625
ities 9.28640365600586e-05
▁as 2.623046875
▁Sky 1.00390625
e 0.0002605915069580078
Ph 0.001544952392578125
arma 0.00021028518676757812
▁un 4.26171875
ve 0.3759765625
ils 0.0004513263702392578
▁this 3.533203125
▁ground 1.955078125
bre 0.266357421875
aking 1.1920928955078125e-06
▁technology 0.0758056640625
. 0.2445068359375
<0x0A> 0.00984954833984375
Expand 3.6796875
ing 0.017333984375
▁Altern 4.99609375
ative 0.051971435546875
▁Rout 3.642578125
es 0.00010335445404052734
▁for 0.4482421875
▁Medic 3.025390625
ation 1.2412109375
▁Administration 0.25927734375
: 0.00672149658203125
<0x0A> 0.0007834434509277344
In 1.6796875
▁addition 0.31005859375
▁to 0.058349609375
▁its 0.3974609375
▁nan 2.234375
ote 0.0018320083618164062
chn 0.008758544921875
ology 0.006336212158203125
▁endeav 3.33203125
ors 0.00795745849609375
, 0.0013093948364257812
▁Sky 0.017242431640625
e 0.00012505054473876953
Ph 0.0010232925415039062
arma 7.11679458618164e-05
▁is 0.449951171875
▁dedicated 3.904296875
▁to 0.0005750656127929688
▁expand 1.95703125
ing 0.000423431396484375
▁alternative 0.50048828125
▁routes 0.177734375
▁for 0.1744384765625
▁drug 3.1796875
▁administration 0.08843994140625
▁that 6.9609375
▁could 3.21875
▁simplify 5.41015625
▁the 1.466796875
▁lives 3.3671875
▁of 0.00177001953125
▁patients 0.13720703125
▁world 2.69140625
wide 6.23464584350586e-05
. 0.01090240478515625
▁The 1.216796875
▁company 0.052276611328125
' 1.046875
s 6.914138793945312e-05
▁ground 6.9296875
bre 0.27880859375
aking 2.1457672119140625e-06
▁work 2.138671875
▁on 2.392578125
▁or 2.24609375
al 0.12420654296875
, 2.44140625
▁nas 1.2763671875
al 0.004024505615234375
, 0.0136260986328125
▁pul 2.4765625
mon 0.0003211498260498047
ary 0.0008573532104492188
, 0.0230865478515625
▁and 0.4697265625
▁trans 0.9541015625
der 0.018218994140625
mal 0.0003924369812011719
▁drug 1.939453125
▁delivery 0.1187744140625
▁offers 4.484375
▁great 4.71875
▁promise 1.62109375
▁to 2.736328125
▁revolution 1.873046875
ize 0.0083160400390625
▁treatment 4.8203125
▁procedures 3.638671875
▁for 2.330078125
▁multiple 5.12890625
▁dise 1.150390625
ases 5.7578086853027344e-05
. 0.2393798828125
▁By 2.134765625
▁foc 4.1796875
using 0.00033926963806152344
▁on 0.0080413818359375
▁impro 2.50390625
ving 0.0004296302795410156
▁patient 1.525390625
▁comp 1.2373046875
liance 0.0003726482391357422
▁and 0.431884765625
▁ease 5.2109375
▁of 0.040924072265625
▁use 1.33984375
, 0.04302978515625
▁Sky 0.287353515625
e 0.00019812583923339844
Ph 0.0007123947143554688
arma 0.0004277229309082031
▁is 1.2470703125
▁po 1.126953125
ised 0.00013267993927001953
▁to 0.066162109375
▁dis 3.091796875
rupt 0.0007214546203613281
▁traditional 3.298828125
▁medic 1.904296875
ation 0.005893707275390625
▁delivery 2.349609375
▁methods 0.378662109375
. 1.0966796875
▁In 2.3125
vest 0.0943603515625
ors 0.014923095703125
▁can 0.394775390625
▁expect 0.58349609375
▁luc 3.15625
r 3.325939178466797e-05
ative 3.218650817871094e-05
▁partners 3.72265625
hips 0.35302734375
▁with 2.9765625
▁ph 1.744140625
arma 0.002574920654296875
ce 0.039794921875
ut 7.152557373046875e-07
ical 5.161762237548828e-05
▁gi 1.5087890625
ants 1.1920928955078125e-07
▁seeking 2.5625
▁to 0.8994140625
▁capital 2.443359375
ize 0.0004925727844238281
▁on 0.00035858154296875
▁these 1.1337890625
▁innov 0.939453125
ative 0.693359375
▁approaches 1.9951171875
. 0.2001953125
<0x0A> 0.009033203125
Str 4.234375
ateg 0.640625
ic 0.1263427734375
▁Coll 1.8662109375
abor 0.00013530254364013672
ations 0.06878662109375
▁and 1.0966796875
▁Market 5.44140625
▁Pot 2.447265625
ential 0.00960540771484375
: 0.02728271484375
<0x0A> 0.001918792724609375
S 0.529296875
ky 0.002368927001953125
e 0.00010657310485839844
Ph 0.0005273818969726562
arma 0.00040149688720703125
▁has 2.01171875
▁consist 4.75
ently 1.4066696166992188e-05
▁engaged 5.17578125
▁in 0.04364013671875
▁strateg 0.47314453125
ic 0.00029206275939941406
▁collabor 0.2705078125
ations 0.0011339187622070312
▁with 0.421142578125
▁global 2.896484375
▁ph 0.49609375
arma 0.0008711814880371094
ce 0.0256805419921875
ut 4.410743713378906e-06
ical 3.9458274841308594e-05
▁companies 0.537109375
, 0.491943359375
▁resulting 3.802734375
▁in 0.00035071372985839844
▁the 2.96484375
▁successful 1.578125
▁commercial 1.24609375
ization 0.0126953125
▁of 0.02215576171875
▁their 3.20703125
▁drug 2.697265625
▁delivery 0.042999267578125
▁techn 0.6806640625
ologies 8.475780487060547e-05
. 0.040740966796875
▁With 1.7587890625
▁ 5.4765625
1 0.7841796875
9 1.1123046875
9 0.069580078125
8 0.0179290771484375
▁expected 3.625
▁to 0.0034198760986328125
▁be 0.216064453125
▁a 0.2685546875
▁year 2.419921875
▁of 0.02227783203125
▁rapid 4.30078125
▁growth 0.452392578125
, 0.84765625
▁these 6.453125
▁collabor 1.2001953125
ations 0.052215576171875
▁will 1.6328125
▁play 2.556640625
▁an 2.337890625
▁instrument 2.638671875
al 1.1682510375976562e-05
▁role 0.004184722900390625
▁in 0.0225372314453125
▁capt 5.3515625
uring 0.057464599609375
▁market 2.080078125
▁share 1.1630859375
▁and 0.7333984375
▁generating 2.119140625
▁substantial 1.6201171875
▁re 0.57275390625
venue 0.0009045600891113281
. 0.32177734375
▁In 1.416015625
vest 0.04498291015625
ors 0.01338958740234375
▁considering 6.91015625
▁Sky 0.64306640625
e 0.00031447410583496094
Ph 0.00074005126953125
arma 0.00014543533325195312
▁will 4.88671875
▁und 2.681640625
ou 0.005767822265625
bt 5.710124969482422e-05
edly 9.775161743164062e-06
▁be 1.5634765625
▁attract 2.173828125
ed 5.435943603515625e-05
▁by 0.94580078125
▁the 0.5361328125
▁company 0.71533203125
' 0.0012607574462890625
s 6.23464584350586e-05
▁commit 3.953125
ment 0.00018107891082763672
▁to 0.004199981689453125
▁collaboration 5.2578125
▁and 0.476806640625
▁experienced 11.1171875
▁leadership 1.77734375
, 1.32421875
▁further 4.5
▁en 1.787109375
han 0.03021240234375
cing 1.3589859008789062e-05
▁their 1.9677734375
▁prospect 2.90625
s 0.0169525146484375
▁for 0.458984375
▁a 3.412109375
▁prosper 1.87890625
ous 0.0001595020294189453
▁future 1.3740234375
. 0.01506805419921875
<0x0A> 0.0160064697265625
D 4.69921875
riv 2.162109375
ing 0.0006031990051269531
▁Success 4.89453125
▁with 0.9541015625
▁a 2.169921875
▁V 2.994140625
ision 0.0294952392578125
: 3.466796875
<0x0A> 0.00839996337890625
S 0.55224609375
ky 0.001361846923828125
e 0.0001125335693359375
Ph 0.0007410049438476562
arma 0.0002655982971191406
▁is 2.359375
▁recognized 6.578125
▁for 0.45751953125
▁its 0.05084228515625
▁un 2.390625
wa 0.13671875
ver 6.9141387939453125e-06
ing 9.059906005859375e-05
▁dedic 1.6728515625
ation 2.86102294921875e-06
▁to 0.0266876220703125
▁innov 1.484375
ation 0.1036376953125
, 1.302734375
▁and 2.3359375
▁its 1.091796875
▁vision 2.63671875
▁has 4.14453125
▁position 4.18359375
ed 3.0279159545898438e-05
▁the 0.53515625
▁company 0.0152435302734375
▁as 0.67919921875
▁a 0.0804443359375
▁fr 3.419921875
on 3.0994415283203125e-06
tr 3.337860107421875e-06
un 0.00013720989227294922
ner 1.9073486328125e-06
▁in 0.01239776611328125
▁the 0.1761474609375
▁ph 0.328369140625
arma 0.0001456737518310547
ce 0.001956939697265625
ut 1.7881393432617188e-06
ical 1.3113021850585938e-05
▁industry 0.0711669921875
. 0.00838470458984375
▁By 1.798828125
▁target 6.6484375
ing 0.0006341934204101562
▁un 2.783203125
met 0.376708984375
▁medical 0.2481689453125
▁needs 0.01045989990234375
, 1.3330078125
▁Sky 2.419921875
e 0.00011289119720458984
Ph 0.0006866455078125
arma 0.00022327899932861328
▁continues 3.822265625
▁to 0.0093994140625
▁create 3.708984375
▁value 2.109375
▁in 5.02734375
▁an 3.236328125
▁increasing 1.216796875
ly 0.0009694099426269531
▁compet 0.133544921875
itive 3.2782554626464844e-05
▁market 0.6318359375
. 0.33251953125
▁Furthermore 5.78125
, 7.200241088867188e-05
▁the 0.76904296875
▁company 0.058013916015625
' 0.155029296875
s 6.365776062011719e-05
▁commit 1.7470703125
ment 9.644031524658203e-05
▁to 0.0013513565063476562
▁deliver 3.65234375
ing 0.0246734619140625
▁on 4.77734375
▁its 0.21142578125
▁promises 0.481689453125
▁and 1.603515625
▁driving 3.998046875
▁prof 4.37109375
itable 0.460205078125
▁growth 0.73974609375
▁ens 3.193359375
ures 0.00012254714965820312
▁invest 2.068359375
ors 0.186279296875
▁are 4.1875
▁well 1.7822265625
- 0.0777587890625
position 0.2286376953125
ed 5.5909156799316406e-05
▁to 1.3671875
▁benefit 1.4912109375
▁from 0.06378173828125
▁their 2.115234375
▁invest 1.0166015625
ments 0.3671875
. 0.1806640625
<0x0A> 0.316162109375
Con 2.5859375
clusion 0.1522216796875
: 0.039947509765625
<0x0A> 10.1328125
The 3.384765625
▁year 2.169921875
▁ 0.07318115234375
1 0.006805419921875
9 0.00012350082397460938
9 0.00016582012176513672
8 0.0005025863647460938
▁holds 2.25390625
▁immense 1.255859375
▁promise 1.2724609375
▁for 0.01230621337890625
▁invest 1.5654296875
ors 0.004810333251953125
▁looking 2.255859375
▁to 0.142822265625
▁capital 0.69482421875
ize 0.0008254051208496094
▁on 0.0007753372192382812
▁bold 4.30078125
▁and 0.1522216796875
▁vision 7.2734375
ary 0.000457763671875
▁ph 2.4765625
arma 0.00023806095123291016
ce 0.0017871856689453125
ut 1.9073486328125e-06
ical 1.6927719116210938e-05
▁endeav 2.73828125
ors 0.0032329559326171875
. 0.035858154296875
▁Sky 0.72509765625
e 7.283687591552734e-05
Ph 0.0006494522094726562
arma 0.00012242794036865234
' 0.7724609375
s 7.236003875732422e-05
▁dedic 3.693359375
ation 1.0609626770019531e-05
▁to 0.0039005279541015625
▁ground 5.4375
bre 0.03277587890625
aking 4.76837158203125e-07
▁drug 1.0361328125
▁delivery 0.01534271240234375
▁nan 2.4765625
ote 0.00010609626770019531
chn 0.00024139881134033203
ology 0.01299285888671875
▁and 0.084228515625
▁alternative 0.404541015625
▁administration 2.23046875
▁routes 0.0306396484375
▁ep 9.6796875
it 5.4717063903808594e-05
om 9.417533874511719e-06
izes 0.1019287109375
▁the 0.51904296875
▁company 0.6005859375
' 0.00109100341796875
s 4.506111145019531e-05
▁commit 0.86181640625
ment 4.7206878662109375e-05
▁to 0.0020904541015625
▁revolution 1.5439453125
izing 0.06103515625
▁patient 1.431640625
▁treatment 3.087890625
. 0.447021484375
▁As 2.013671875
▁invest 3.029296875
ors 0.049285888671875
▁seek 1.20703125
▁potentially 7.30078125
▁high 4.23828125
- 0.23779296875
g 2.2578125
row 0.0217132568359375
th 0.00048160552978515625
▁vent 1.7646484375
ures 0.0004725456237792969
, 0.2027587890625
▁Sky 0.1507568359375
e 0.00013113021850585938
Ph 0.0005445480346679688
arma 4.7087669372558594e-05
▁emer 5.28125
ges 0.0002605915069580078
▁as 0.003543853759765625
▁an 1.5322265625
▁ent 3.833984375
icing 0.006443023681640625
▁opportunity 1.5107421875
, 1.234375
▁po 1.9296875
ised 0.002178192138671875
▁to 0.12939453125
▁maintain 8.40625
▁its 0.1329345703125
▁up 4.578125
ward 0.0112457275390625
▁traject 0.04376220703125
ory 3.62396240234375e-05
▁in 1.380859375
▁the 0.6435546875
▁ph 3.0625
arma 8.761882781982422e-05
ce 0.0031032562255859375
ut 5.054473876953125e-05
ical 1.2755393981933594e-05
▁industry 0.50537109375
. 0.04443359375
▁With 2.755859375
▁a 1.6201171875
▁remarkable 5.84375
▁vision 3.55859375
▁and 0.348876953125
▁a 1.6181640625
▁track 2.458984375
▁record 0.001911163330078125
▁of 0.004657745361328125
▁success 0.49755859375
, 0.0158843994140625
▁Sky 0.7412109375
e 0.00011873245239257812
Ph 0.0006957054138183594
arma 0.00018715858459472656
▁a 5.796875
ims 0.1473388671875
▁to 0.0092926025390625
▁transform 3.755859375
▁the 0.496337890625
▁lives 2.34375
▁of 0.001590728759765625
▁millions 1.521484375
▁while 4.1953125
▁providing 2.099609375
▁invest 0.8662109375
ors 0.0086517333984375
▁with 0.0662841796875
▁a 2.00390625
▁mag 13.1640625
ical 0.03863525390625
▁year 2.697265625
▁of 1.357421875
▁growth 1.79296875
▁in 2.697265625
▁ 0.0189666748046875
1 0.002079010009765625
9 6.556510925292969e-05
9 0.00015032291412353516
8 0.0004544258117675781
. 0.0213470458984375
